Mark Libenson, MD
NPI 1174541932 · Neurology with Special Qualifications in Child Neurology Physician · Boston, MA
Enrolled with Medicare as Practitioner - Neurology · source: CMS PECOS Public Provider Enrollment (2026.04.01)
Mark Libenson, MD is a Neurology with Special Qualifications in Child Neurology Physician provider in Boston, MA (NPI 1174541932).
Provider details
- NPI number
- 1174541932
- Entity type
- Individual
- Primary specialty
- Neurology with Special Qualifications in Child Neurology PhysicianAllopathic & Osteopathic Physicians
- Credential
- MD
- Sex
- Male
- Sole proprietor
- No
- License
- 60519 (MA)
Specialties & taxonomies
- Neurology with Special Qualifications in Child Neurology PhysicianPrimary2084N0402XLicense 60519 (MA)
Allopathic & Osteopathic Physicians
Allopathic & Osteopathic Physicians
Profile Score
A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.
- Registry tenure38% of score
19 yrs in NPPES registry
- Profile completeness38% of score
100% of core fields populated
- Practice footprint23% of score
1 documented practice location
Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our methodology.
What this provider prescribes (Medicare Part D)
Top drugs by Medicare Part D claim volume, 2024 · 9 distinct drugs on file.
| Drug | Part D claims (2024) |
|---|---|
| Clobazam | 52 |
| Carbamazepinebrand: Carbamazepine Er | 44 |
| Divalproex Sodium | 27 |
| Lamotrigine | 23 |
| Lacosamide | 18 |
| Divalproex Sodiumbrand: Depakote Sprinkle | 16 |
| Lamotriginebrand: Lamictal Xr | 13 |
| Divalproex Sodiumbrand: Divalproex Sodium Er | 12 |
| Oxcarbazepine | 11 |
Medicare Part D only. These counts cover prescriptions paid through Medicare Part D in 2024 — they do notinclude cash-pay, commercial-insurance, Medicaid, or Part B–administered drugs, and badly undercount high cash-pay categories (e.g. GLP-1 weight-loss, testosterone, and ED medications). Any drug with 10 or fewer claims is omitted by CMS, and beneficiary counts under 11 are suppressed — so a missing drug means , never zero. This is a factual claims summary, not an endorsement, not medical advice, and not a consumer report. Source: CMS Medicare Part D Prescribers — by Provider and Drug.
Practice location
Mailing address
Registry dates
- Enumerated
- 2006-07-18
- Last updated
- 2007-08-24
Frequently asked questions
- What is Mark Libenson's NPI number?
- Mark Libenson's National Provider Identifier (NPI) is 1174541932, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.
- What is Mark Libenson's specialty?
- Mark Libenson is listed in the NPPES registry with a primary specialty of Neurology with Special Qualifications in Child Neurology Physician (Allopathic & Osteopathic Physicians).
- Where is Mark Libenson located?
- Mark Libenson's practice location on file with NPPES is 300 Longwood Ave, Boston, MA 02115-5724.
- What is Mark Libenson's phone number?
- The practice phone number listed in the NPPES registry for Mark Libenson is (617) 355-8071.
- Does Mark Libenson accept Medicare?
- Mark Libenson is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.
- Is Mark Libenson's NPI active?
- Yes — Mark Libenson's NPI (1174541932) is active in the NPPES registry as of the last update on 2007-08-24.
Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.